Codexis, Inc (NASDAQ:CDXS) Unveils Its Financial Results For The Year Ended 2017 Biotech By Louisa Hendrickson / April 20, 2018 Codexis, Inc (NASDAQ:CDXS) has proceeded to announce its 2017 financial results for the three and 12 Continue reading > Share
Shares Of Conatus Pharmaceuticals Inc (NASDAQ:CNAT) Sink After The Failure Of A New Study Biotech By Louisa Hendrickson / April 20, 2018 The shares of Conatus Pharmaceuticals Inc (NASDAQ:CNAT) declined by about 33% and that followed a recent Continue reading > Share
Crispr Therapeutics AG (NASDAQ:CRSP) Presents Positive Data In Line With The CAR-T Cell Therapies Biotech By Louisa Hendrickson / April 19, 2018 The stock of Crispr Therapeutics AG (NASDAQ:CRSP) closed at $51.18 losing 1.14% in yesterday’s trading Continue reading > Share
NuCana PLC (ADR) (NASDAQ:NCNA) Appoints Adam George As Chairman Of Audit Committee Biotech By Louisa Hendrickson / April 18, 2018 NuCana PLC (ADR) (NASDAQ:NCNA) announced recently that it has appointed Adam George as the new member Continue reading > Share
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Receives Breakthrough Therapy Designation Biotech By Louisa Hendrickson / April 18, 2018 Fennec Pharmaceuticals Inc (NASDAQ:FENC) announced recently that the US Food and Drug Administration Continue reading > Share
Marrone Bio Innovations Inc (NASDAQ:MBII) Stocks Spike After A Research Firm’s ‘Decent Pick’ Recommendation Biotech By Louisa Hendrickson / April 17, 2018 Marrone Bio Innovations Inc (NASDAQ:MBII) shares rose 21.7% last week after Zacks Equity Research recommended Continue reading > Share
Codexis, Inc. (NASDAQ:CDXS) Appoints Shawn Clairmont As Senior Director Prior To Making Presentation At A Science Corporation Biotech By Louisa Hendrickson / April 17, 2018 Codexis, Inc. (NASDAQ:CDXS) recently appointed Shawn Clairmont as the Senior Director, Molecular Diagnostics Continue reading > Share
Sellas Life Sciences Group Inc (NASDAQ:SLS) Positive Phase 2 Breast Cancer Trial Data Send Stocks Skyrocketing Biotech By Louisa Hendrickson / April 17, 2018 Sellas Life Sciences Group Inc (NASDAQ:SLS) shares skyrocketed after the successful Phase 2 interim Continue reading > Share
Innovate Biopharmaceuticals Inc (NASDAQ:INNT) Brings Onboard June Almenoff As Its New CEO Biotech By Ash Rocks / April 5, 2018 Innovate Biopharmaceuticals Inc (NASDAQ:INNT) today proceeded to name its newly appointed Chief Operating Continue reading > Share
KemPharm Inc (NASDAQ:KMPH) Unleashes Fourth Quarter And Year End Corporate And Financial Results Biotech By Louisa Hendrickson / April 4, 2018 The stock of KemPharm Inc (NASDAQ:KMPH) closed at $6.55 losing 3.68% in yesterday’s trading session. Continue reading > Share